{"id":"https://openalex.org/W3211604201","doi":"https://doi.org/10.1182/blood-2021-147148","title":"Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients","display_name":"Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3211604201","doi":"https://doi.org/10.1182/blood-2021-147148","mag":"3211604201"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-147148","doi":"https://doi.org/10.1182/blood-2021-147148","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-147148","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048522027","display_name":"Shalev Fried","orcid":"https://orcid.org/0000-0003-1306-222X","observed_orcids":["https://orcid.org/0000-0003-1306-222X"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Shalev Fried","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003511896","display_name":"Ivetta Danylesko","orcid":"https://orcid.org/0000-0002-0627-5502","observed_orcids":["https://orcid.org/0000-0002-0627-5502"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ivetta Danylesko","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081737366","display_name":"Ronit Yerushalmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ronit Yerushalmi","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045152818","display_name":"Noga Shem\u2010Tov","orcid":"https://orcid.org/0000-0003-1589-9189","observed_orcids":["https://orcid.org/0000-0003-1589-9189"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Noga Shem-Tov","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033851673","display_name":"Roni Shouval","orcid":"https://orcid.org/0000-0001-9827-8032","observed_orcids":["https://orcid.org/0000-0001-9827-8032"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL","US"],"is_corresponding":false,"raw_author_name":"Roni Shouval","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Memorial Sloan Kettering Cancer Center, New York, NY","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029993254","display_name":"Joshua Alexander Fein","orcid":"https://orcid.org/0000-0001-5441-1516","observed_orcids":["https://orcid.org/0000-0001-5441-1516"]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]},{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua A Fein","raw_affiliation_strings":["University of Connecticut Medical Center, Farmington, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut Medical Center, Farmington, CT","institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103080201","display_name":"Zachary Cohen","orcid":"https://orcid.org/0000-0002-8518-0180","observed_orcids":["https://orcid.org/0000-0002-8518-0180"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Zachary Cohen","raw_affiliation_strings":["Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087021014","display_name":"Elad Jacoby","orcid":"https://orcid.org/0000-0003-1411-8942","observed_orcids":["https://orcid.org/0000-0003-1411-8942"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I4210144215","display_name":"Edmond and Lily Safra Children's Hospital","ror":"https://ror.org/04jbyz122","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210144215"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Elad Jacoby","raw_affiliation_strings":["Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel","institution_ids":["https://openalex.org/I2799810450","https://openalex.org/I4210144215"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055924804","display_name":"Michal Judith Besser","orcid":"https://orcid.org/0000-0002-9233-0458","observed_orcids":["https://orcid.org/0000-0002-9233-0458"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Michal Besser","raw_affiliation_strings":["Chaim Sheba Medical Center, Ella Lemelbaum Institute for Immuno Oncology, Tel Hashomer, Israel","Sackler School of Medicine, Department of Clinical Microbiology and Immunology, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chaim Sheba Medical Center, Ella Lemelbaum Institute for Immuno Oncology, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Department of Clinical Microbiology and Immunology, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058925624","display_name":"Arnon Nagler","orcid":"https://orcid.org/0000-0002-0763-1265","observed_orcids":["https://orcid.org/0000-0002-0763-1265","https://orcid.org/0000-0002-6126-884X"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Arnon Nagler","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020301140","display_name":"Avichai Shimoni","orcid":"https://orcid.org/0000-0001-8782-6160","observed_orcids":["https://orcid.org/0000-0001-8782-6160"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Avichai Shimoni","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011217358","display_name":"Abraham Avigdor","orcid":"https://orcid.org/0000-0002-7448-869X","observed_orcids":["https://orcid.org/0000-0002-7448-869X"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Abraham Avigdor","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"910","last_page":"910"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.09359999746084213,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.04740000143647194,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8949999809265137},{"id":"https://openalex.org/keywords/primary-mediastinal-large-b-cell-lymphoma","display_name":"primary mediastinal B-cell lymphoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/relapsed-lymphoma","display_name":"relapsed lymphoma","score":0.6480000019073486},{"id":"https://openalex.org/keywords/transplant-related-toxicity","display_name":"transplant toxicity","score":0.5170000195503235},{"id":"https://openalex.org/keywords/graft-versus-tumor-effect","display_name":"graft-versus-tumor effect","score":0.722000002861023},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.6629999876022339},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.46399998664855957},{"id":"https://openalex.org/keywords/cd28-costimulation","display_name":"CD28 costimulation","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7923648357391357},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6295386552810669},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5909092426300049},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.5834683179855347},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5811078548431396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5600305795669556},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4416925311088562},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4357272982597351},{"id":"https://openalex.org/C2781214270","wikidata":"https://www.wikidata.org/wiki/Q4692282","display_name":"Aggressive lymphoma","level":4,"score":0.4197770953178406},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33166050910949707},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.3070050776004791},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2348632514476776},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1613582968711853}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-147148","doi":"https://doi.org/10.1182/blood-2021-147148","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-147148","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4285386994","https://openalex.org/W4308308459","https://openalex.org/W3024551293","https://openalex.org/W74443612","https://openalex.org/W2913561175","https://openalex.org/W4412564623","https://openalex.org/W2950573761","https://openalex.org/W4417011524","https://openalex.org/W3103895069","https://openalex.org/W3016727307"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Approximately":[2],"60%":[3],"of":[4,51,74,121,128,179,190,205,384,404,439,502,522,539,555,599,612,630,649,670],"patients":[5,38,59,71,77,96,140,165,191,474,483,490,515,530,573,631],"with":[6,13,100,187,378,475,479,491,495,607,627],"aggressive":[7,57,604],"large":[8],"B-cell":[9],"lymphoma":[10,37,58],"(ALBCL)":[11],"treated":[12,99,478],"anti-CD19":[14,101],"chimeric":[15],"antigen":[16],"receptor":[17],"T-cell":[18,43,103,601],"(CAR":[19],"T)":[20],"will":[21],"ultimately":[22],"progress":[23],"or":[24,672],"relapse.":[25],"Allogeneic":[26,591],"hematopoietic":[27,153,592],"cell":[28,154,593],"transplantation":[29,594],"(Allo-HCT)":[30],"is":[31,595,625],"a":[32,119,142,149,167,177,371,379,434,608],"potentially":[33],"curative":[34],"treatment":[35],"for":[36,87,201,433],"who":[39,84],"relapse":[40,227,353],"after":[41,229,597],"CAR":[42,54,102,132,185,198,210,222,230,388,407,421,600],"therapy.":[44],"However,":[45],"the":[46,188,402,647],"efficacy":[47],"and":[48,70,115,123,226,245,260,268,277,297,305,330,337,345,355,363,390,401,409,423,448,459,481,497,528,574,585,614,634],"toxicity":[49],"profile":[50],"allo-HCT":[52,86,202,237,391,410,427,650],"following":[53],"T":[55,133,211,223,231,389,408,422],"in":[56,212,274,291,302,456,553,562,570,603,618,651],"are":[60,642],"not":[61,429,468],"well":[62],"defined.":[63],"Herein,":[64],"we":[65],"report":[66],"our":[67],"experience.":[68],"Methods":[69],"A":[72],"total":[73],"29":[75],"adult":[76],"(median":[78],"age":[79],"45":[80],"years":[81],"[IQR":[82],"40-55])":[83],"received":[85],"ALBCL":[88],"between":[89,387,406],"2017":[90],"to":[91,209,221,328,420,470,526,533,644],"2021":[92],"were":[93,97,203,251,272,300,340,358,382,428,454,467,477,493,524],"included.":[94],"All":[95,473],"previously":[98],"(academic":[104],"CD28-costimulatory":[105],"domain":[106],"product":[107],"[n=23,":[108],"79%];":[109],"tisagenlecleucel":[110],"[n=6,":[111],"21%]).":[112],"Twenty-five":[113],"(86%)":[114],"4":[116,521,554],"(14%)":[117],"had":[118,166,516],"diagnosis":[120],"DLBCL":[122],"PMBCL,":[124],"respectively.":[125,281,308,350,463],"Median":[126,152,310],"number":[127,383],"previous":[129,143,150],"therapies":[130,386],"before":[131,236,325,426],"was":[134,159,174,238,289,312,320,507,542,550,560],"3":[135,160,442,529],"(IQR":[136,161,182,315],"2-4).":[137],"Eight":[138],"(28%)":[139],"underwent":[141,148],"autologous":[144],"HCT.":[145],"No":[146],"patient":[147],"allo-HCT.":[151],"transplantation-specific":[155],"comorbidity":[156],"index":[157],"(HCT-CI)":[158],"2-3).":[162],"Six":[163],"(21%)":[164,572],"Karnofsky":[168],"performance":[169],"status":[170],"\u2264":[171],"80%.":[172],"Allo-HCT":[173],"performed":[175],"at":[176,636],"median":[178],"4.1":[180],"months":[181,314],"2.2-5.4)":[183],"post":[184,197],"T,":[186],"majority":[189],"(48%)":[192],"receiving":[193],"transplant":[194],"as":[195],"first-line":[196],"T.":[199],"Reasons":[200],"consolidation":[204],"complete":[206],"response":[207,219,235,419,425],"(CR)":[208],"high-risk":[213],"disease":[214,247,286,424],"(n=4,":[215],"14":[216],"%),":[217],"partial":[218],"(PR)":[220],"(n=7,":[224,248,265],"24%)":[225],"/progression":[228],"(n=18,":[232],"62%).":[233],"Disease":[234],"CR":[239],"(n=11,":[240,243],"38%),":[241],"PR":[242],"38%)":[244],"progressive":[246],"24%).":[249,266],"Donors":[250],"matched":[252,256],"siblings":[253],"(n=13,":[254],"45%),":[255],"unrelated":[257,262],"(n=9,":[258],"31%)":[259],"mismatched":[261],"/haploidentical":[263],"donors":[264],"Myeloablative":[267],"reduced-intensity":[269],"conditioning":[270],"regimens":[271],"given":[273],"13":[275,303],"(45%)":[276,304],"16":[278],"(55%)":[279],"patients,":[280,462],"Methotrexate-based":[282],"graft":[283],"versus":[284],"host":[285],"(GVHD)":[287],"prophylaxis":[288],"used":[290],"20":[292],"(69%)":[293],"patients.":[294,565,622],"Antithymocyte":[295],"globulin":[296],"post-transplantation":[298],"cyclophosphamide":[299],"administered":[301],"5":[306,460],"(14%),":[307],"Results":[309],"follow-up":[311],"33":[313],"13-41).":[316],"Neutrophil":[317],"engraftment":[318,326],"rate":[319,611],"93%":[321],"(two":[322],"early":[323],"deaths":[324],"due":[327,532],"infection":[329,559,568],"multi-organ":[331],"failure).":[332],"Two-year":[333,351,536],"overall":[334],"survival":[335,339,624],"(OS)":[336],"progression-free":[338],"44%":[341],"(95%":[342,347,360,365],"CI:":[343,348,361,366,397,414,511,546],"28-68)":[344],"30%":[346,629],"17-55),":[349],"cumulative":[352,500,537],"incidence":[354,501,538],"non-relapse":[356],"mortality":[357],"45%":[359],"25-63)":[362],"25%":[364],"11-43),":[367],"respectively":[368],"(Figure).":[369],"In":[370],"univariable":[372],"Cox":[373],"regression,":[374],"factors":[375,432],"significantly":[376],"associated":[377],"shorter":[380,435],"OS":[381],"interim":[385],"(Hazard":[392],"ratio":[393],"[HR]":[394],"2.2":[395],"[95%":[396,413],"1.3-3.9],":[398],"p":[399,416],"0.006)":[400],"length":[403],"time":[405],"(HR":[411],"3.8":[412],"1.2-12.1],":[415],"0.02).":[417],"Best":[418],"significant":[430],"risk":[431],"OS.":[436],"High":[437],"rates":[438],"grade":[440,503,517],"\u2265":[441],"hyperbilirubinemia":[443],"(total":[444],"bilirubin":[445],">3":[446],"ULN)":[447],"hepatic":[449],"sinusoidal":[450],"obstruction":[451],"syndrome":[452],"(SOS)":[453],"observed":[455],"10":[457],"(35%)":[458],"(17%)":[461],"These":[464],"liver":[465],"insults":[466],"contributed":[469],"acute":[471,505,519,534,616],"GVHD.":[472,535],"SOS":[476,492,613],"defibrotide":[480],"two":[482,637],"died":[484,531],"from":[485],"related":[486],"complications.":[487],"Interestingly,":[488],"4/5":[489],"conditioned":[494],"fludarabine":[496],"thiotepa.":[498],"One-year":[499],"II-IV":[504],"GVHD":[506,541,549,617],"34%":[508],"(n=10;":[509],"95%":[510,545],"18-52).":[512],"Notably,":[513],"6":[514,571],"IV":[518],"GVHD,":[520],"them":[523],"refractory":[525],"corticosteroids":[527],"chronic":[540],"23%":[543],"(n=5;":[544],"7-46).":[547],"Chronic":[548],"considered":[551],"extensive":[552],"them.":[556],"Bloodstream":[557],"bacterial":[558],"documented":[561],"11":[563],"(38%)":[564],"Invasive":[566],"fungal":[567],"occurred":[569],"included":[575],"brain":[576],"aspergillosis,":[577,579,582],"cutaneous":[578],"2":[580],"lung":[581],"hepatosplenic":[583],"candidiasis":[584],"an":[586,667],"ocular":[587],"mucor":[588],"mycosis.":[589],"Conclusion":[590],"feasible":[596],"failure":[598],"therapy":[602],"lymphoma,":[605],"although":[606],"relatively":[609],"high":[610],"severe":[615],"these":[619],"heavily":[620],"pretreated":[621],"Overall":[623],"encouraging":[626],"approximately":[628],"remaining":[632],"alive":[633],"disease-free":[635],"years.":[638],"Larger":[639],"scale":[640],"studies":[641],"required":[643],"better":[645],"define":[646],"role":[648],"this":[652],"setting.":[653],"Figure":[654,656],"1":[655],"1.":[657],"Disclosures":[658],"Shouval:":[659],"Medexus:":[660],"Consultancy.":[661],"Jacoby:":[662],"NOVARTIS:":[663],"Honoraria,":[664],"Membership":[665],"on":[666],"entity's":[668],"Board":[669],"Directors":[671],"advisory":[673],"committees.":[674],"Avigdor:":[675],"Takeda:":[676],"Consultancy,":[677,686,689],"Honoraria;":[678,687],"Janssen:":[679],"Research":[680,683],"Funding;":[681,684],"BMS:":[682],"Gilead:":[685],"Pfizer:":[688],"Honoraria.":[690]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2021-11-22T00:00:00"}
